Edwards Lifesciences Corp Operating Income Loss

• Edwards Lifesciences Corp showed a decrease of -8.3% in Operating Income Loss from 2024 to 2025.
• This data is from Edwards Lifesciences Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Edwards Lifesciences Corp's Operating Income Loss has grown by 68.3%.
• Historical annual values: Fiscal year 2025: $1.26 billion | Fiscal year 2024: $1.38 billion | Fiscal year 2023: $1.31 billion | Fiscal year 2022: $1.50 billion | Fiscal year 2021: $1.69 billion | Fiscal year 2020: $897.60 million | Fiscal year 2019: $1.15 billion | Fiscal year 2018: $748.20 million | Fiscal year 2017: $1.09 billion | Fiscal year 2016: $751.20 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026